Australia markets open in 4 hours 2 minutes

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.13-0.18 (-2.46%)
As of 03:58PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
44,952
21,252
1,535
0
170
Cost of revenue
1,714
1,259
86
0
-
Gross profit
43,238
19,993
1,449
0
-
Operating expenses
Research development
55
56
3,531
4,981
5,105
Selling general and administrative
36,941
32,708
20,507
12,242
12,950
Total operating expenses
37,231
33,051
24,187
17,223
18,055
Operating income or loss
6,007
-13,058
-22,738
-17,223
-17,885
Interest expense
3,630
3,394
978
126
9
Total other income/expenses net
-62
-34
-193
-35
100
Income before tax
2,844
-16,045
-23,714
-17,346
-18,109
Income from continuing operations
2,844
-16,045
-23,714
-17,346
-18,109
Net income
2,844
-16,045
-23,714
-17,346
-18,109
Net income available to common shareholders
2,844
-16,045
-23,714
-17,346
-18,109
Basic EPS
-0.75
-0.60
-0.90
-0.67
-0.76
Diluted EPS
-0.75
-0.60
-0.90
-0.67
-0.76
Basic average shares
26,589
26,574
26,275
26,006
23,704
Diluted average shares
26,589
26,574
26,275
26,006
23,704